Will CROs Take On the Risks of Strategic Outsourcing?

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2004
Volume 28
Issue 6

It's not clear whether contract service providers can deliver the performance improvements and costs savings that drug companies expect from large, long-term, semi-exclusive contracts.

Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Related Content